Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Multiple Myeloma trials
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Study Type: Observational
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
Study Type: Interventional Phase 2
Stem Cell Transplantation for Patients With Multiple Myeloma
Study Type: Interventional Phase 1
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Study Type: Interventional Phase 1
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
Study Type: Interventional Phase 1
GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies
Study Type: Interventional Phase 1
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Study Type: Observational
There are 515 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now